RecruitingNot applicableNCT03061435
Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
Studying Vulvar squamous cell carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Dr. Danielle Vicus
- Principal Investigator
- Danielle Vicus, MDOdette Cancer Centre
- Intervention
- Screening anal Pap smear - No high-resolution anoscopy(procedure)
- Enrollment
- 110 enrolled
- Eligibility
- 40 years · FEMALE
- Timeline
- 2021 – 2026
Study locations (1)
- Odette Cancer Centre, Toronto, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03061435 on ClinicalTrials.govOther trials for Vulvar squamous cell carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06358469STRatIfication of Vulvar SCC by HPV and p53 Status to Guide ExcisionCanadian Cancer Trials Group
- RECRUITINGPHASE2NCT06023862A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)Yonsei University
- RECRUITINGNCT05242861Retrospective Study of BrachytherapyZhejiang Cancer Hospital